José Luis Moreno, PhD

jose luis moreno

Graduate in Biochemistry and Doctor in Sciences by the Universidad Autónoma de Madrid. He has developed his professional career in several research fields including virology, G protein-coupled receptors and gene therapy in Spain, in the US, and in the UK.

Jose L. Moreno has received training and education on Biochemistry at the Universidad Autónoma de Madrid. His graduate research training started when he joined the laboratory of Dr. Luis Enjuanes at the Center of National Biotechnology (CNB-CSIC). His PhD work was focused on the study of the molecular mechanisms involved in coronavirus transcription. The final goal of the investigation was to regulate virus gene expression to develop attenuated viruses for vaccines and gene therapy.

After graduation, he joined the laboratory of Dr. Javier Gonzalez-Maeso at Mount Sinai School of Medicine in New York (United States) as a postdoctoral fellow. The goal of his research was to explore the structure, function and regulation of G protein-coupled receptors (GPCRs), translating this basic knowledge into novel strategies to treat psychiatric disorders.

Jose Luis continued his investigations in the GPCR field in the Virginia Commonwealth University (VCU), in Richmond (United States). There, he was a project manager in charge of the project “Maternal immune activation during pregnancy: Implications for schizophrenia development and brain plasticity”.

Later, he joined GlaxoSmithKline (GSK) in Stevenage (United Kingdom) as a Senior Scientist, at the Cell and Gene Therapy Platform. He was responsible of product development and supply of viral vectors formulation used in gene therapy clinical trials.

At present, he is the Head of the Analytical Department at VIVEbiotech.

Contact us

Mikeletegi Pasealekua 81, San Sebastián 20009, Gipuzkoa (SPAIN)